CLOSURE develops adhesive for emphysema:
This article was originally published in Clinica
CLOSURE Medical is developing an adhesive product for the minimally invasive treatment of emphysema. The adhesive is to be used during an endobronchial lung volume reduction (LVR) procedure to achieve bronchial occlusion, which causes the dysfunctional lung tissue to collapse, making room for the expansion of healthier lung tissue. A feasibility study of the product in 10 goats showed that it achieved LVR in all the animals. The Raleigh, North Carolina company is to conduct another animal study to optimise the procedure before entering human trials.
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.